Growth Metrics

Accuray (ARAY) Short-term Investments (2012 - 2026)

Accuray posted quarterly Short-term Investments of $467000.0 for Q1 2026, down 18.78% on a QoQ basis from $575000.0 in Q4 2025.

Accuray (ARAY) has 10 years of Short-term Investments data on file, last reported at $467000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Short-term Investments changed N/A year-over-year to $467000.0; the trailing twelve-month figure through Mar 2026 stood at $467000.0 (changed N/A YoY), and the FY2024 full-year result was $485000.0, changed N/A from the prior year.
  • Short-term Investments for Q1 2026 stood at $467000.0, down from $575000.0 in the prior quarter.
  • Across five years, Short-term Investments topped out at $575000.0 in Q4 2025 and bottomed at $467000.0 in Q1 2026.
  • The 3-year median for Short-term Investments is $528500.0 (2024), against an average of $524750.0.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Accuray 47,295.88 -38.49 Mn 25.29 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 467,000.00
Dec 31, 2025 575,000.00
Sep 30, 2025 572,000.00
Jun 30, 2024 485,000.00
Jun 30, 2018 83.08 Mn
Mar 31, 2018 888,000.00
Dec 31, 2017 24.52 Mn
Sep 30, 2017 23.93 Mn
Jun 30, 2017 23.91 Mn
Mar 31, 2017 23.91 Mn
Dec 31, 2016 38.91 Mn
Sep 30, 2016 40.81 Mn
Jun 30, 2016 47.24 Mn
Mar 31, 2016 70.65 Mn
Dec 31, 2015 67.30 Mn
Sep 30, 2015 67.51 Mn
Jun 30, 2015 64.31 Mn
Mar 31, 2015 54.19 Mn
Dec 31, 2014 53.52 Mn
Sep 30, 2014 45.42 Mn
Jun 30, 2014 79.55 Mn
Mar 31, 2014 86.01 Mn
Dec 31, 2013 89.20 Mn
Sep 30, 2013 99.16 Mn
Jun 30, 2013 12.76 Mn
Jun 30, 2012 6.74 Mn